Pipobroman
From Infogalactic: the planetary knowledge core
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
3-bromo-1-[4-(3-bromopropanoyl) piperazin-1-yl]-propan-1-one
|
|
| Clinical data | |
| Trade names | Vercite, Vercyte |
| AHFS/Drugs.com | International Drug Names |
| Identifiers | |
| CAS Number | 54-91-1  |
| ATC code | L01AX02 (WHO) |
| PubChem | CID: 4842 |
| IUPHAR/BPS | 7271 |
| DrugBank | DB00236 |
| ChemSpider | 4676 |
| UNII | 6Q99RDT97R |
| KEGG | D00467 |
| ChEMBL | CHEMBL1585 |
| Chemical data | |
| Formula | C10H16Br2N2O2 |
| Molecular mass | 356.054 g/mol |
|
|
|
|
| (verify) | |
Pipobroman (trade names Vercite, Vercyte) is an anti-cancer drug that probably acts as an alkylating agent.[1] It is marketed by Abbott Laboratories.[2]
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references> tag; parameter "group" is allowed only.
<references />, or <references group="..." /><templatestyles src="Asbox/styles.css"></templatestyles>
 |
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Drugs.com: Pipobroman
